These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2674985)

  • 21. Costs and benefits of prostate cancer screening. Investigators of the American Cancer Society--National Prostate Cancer Detection Project.
    Littrup PJ; Goodman AC
    In Vivo; 1994; 8(3):423-7. PubMed ID: 7803728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case-control prostate cancer screening studies should not exclude subjects with lower urinary tract symptoms.
    Godley PA; Carpenter WR
    J Clin Epidemiol; 2007 Feb; 60(2):176-80. PubMed ID: 17208124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of prostate-specific antigen (PSA) and PSA density in the detection of stage T1 carcinoma of the prostate.
    Presti JC; Carroll PR
    Semin Urol Oncol; 1996 Aug; 14(3):134-8. PubMed ID: 8865474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of percent free PSA for prostate cancer detection in men with a total PSA of 4-10 ng/ml.
    Bermúdez-Tamayo C; Martín Martín JJ; González Mdel P; Pérez Romero C
    Urol Int; 2007; 79(4):336-44. PubMed ID: 18025853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran.
    Hosseini SY; Moharramzadeh M; Ghadian AR; Hooshyar H; Lashay AR; Safarinejad MR
    Int J Urol; 2007 May; 14(5):406-11. PubMed ID: 17511722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter study on the detection of prostate cancer by digital rectal examination and prostate-specific antigen in men with or without urinary symptoms. Cooperative Group for Diagnosis of Prostate Cancer.
    Eur Urol; 1997; 32(2):133-9. PubMed ID: 9286642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. US doctors urge a more cautious approach to screening for prostate cancer.
    Roehr B
    BMJ; 2010 Mar; 340():c1293. PubMed ID: 20203078
    [No Abstract]   [Full Text] [Related]  

  • 28. Screening for prostate cancer: is ultrasound the answer?
    Mustin HD; Carter AP; Sailer JF; Thompson LW
    HMO Pract; 1990; 4(5):157-61. PubMed ID: 10107263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transrectal US of the prostate: is the technology leading the science?
    McClennan BL
    Radiology; 1988 Aug; 168(2):571-5. PubMed ID: 3293115
    [No Abstract]   [Full Text] [Related]  

  • 30. [Multicenter national Polish population health status tests--WOBASZ project. Establishment of methods and logistics].
    Rywik S; Kupść W; Piotrowski W; Broda G; Piwoński J; Kurjata P; Waśkiewicz A; Gaździk D;
    Kardiol Pol; 2005; 63(6 Suppl 4):S605-13. PubMed ID: 20527431
    [No Abstract]   [Full Text] [Related]  

  • 31. The next era for prostate cancer. Controlled clinical trials.
    Lange PH
    JAMA; 1993 Jan; 269(1):95-6. PubMed ID: 8416416
    [No Abstract]   [Full Text] [Related]  

  • 32. [The progress in mass screening for prostatic diseases by transrectal ultrasonotomography].
    Watanabe H; Ohe H; Saitoh M; Itakura Y; Nakao M
    Nihon Hinyokika Gakkai Zasshi; 1985 Jun; 76(6):913-20. PubMed ID: 3906215
    [No Abstract]   [Full Text] [Related]  

  • 33. Branding the ERSPC: a waste or a need?
    Denis LJ
    BJU Int; 2003 Dec; 92 Suppl 2():115-6. PubMed ID: 14983968
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention trial for prostate cancer piques public interest.
    Donodeo F
    J Natl Cancer Inst; 1993 Nov; 85(22):1801-2. PubMed ID: 8230258
    [No Abstract]   [Full Text] [Related]  

  • 35. Prostatic cancer: future prospects for diagnosis and screening.
    Franks LM
    Br J Urol; 1997 Mar; 79 Suppl 1():107-8. PubMed ID: 9088283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for prostatic cancer.
    Moss S; Ellman R; Melia J; Chamberlain J
    BMJ; 1993 Mar; 306(6881):856. PubMed ID: 8490390
    [No Abstract]   [Full Text] [Related]  

  • 37. Information over exaggeration.
    Brawley OW
    US News World Rep; 2009 Dec; 146(11):24. PubMed ID: 20027814
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening for prostatic cancer.
    Friedman GD; Hiatt RA; Quesenberry CP; Selby JV
    Lancet; 1991 Nov; 338(8777):1271-2. PubMed ID: 1682665
    [No Abstract]   [Full Text] [Related]  

  • 39. Screening for prostatic cancer.
    Nigam AK
    BMJ; 1993 Mar; 306(6881):855-6. PubMed ID: 8338558
    [No Abstract]   [Full Text] [Related]  

  • 40. Screening for prostatic cancer.
    Harwood RH
    BMJ; 1993 Mar; 306(6881):855. PubMed ID: 8490387
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.